Table 1: Patient demographic and clinical characteristics at baseline
(total and differences according insulin treatment). Values are
expressed as mean ± standard deviation (SD). DPP-4 Inhibitors:
dipeptidyl peptidase-4 inhibitors; SGLT2 Inhibitors: sodium glucose
cotransporter 2 inhibitors. eGFR: estimated glomerular filtrate rate.
ACEIs/ARBs: Angiotensin-converting-enzyme inhibitors/Angiotensin II
receptor blockers.
Table 2